Home / Business and Economy / UNH Faces Earnings Test Amid Cost Pressures
UNH Faces Earnings Test Amid Cost Pressures
6 Apr
Summary
- UnitedHealth stock fell 15% year-to-date due to rising costs.
- Analysts project 32% upside for UNH stock.
- Q1 earnings expected to drop 8% due to higher medical costs.
UnitedHealth (UNH) is scheduled to announce its first-quarter fiscal 2026 financial results on April 21. The company's stock has experienced a significant downturn this year, declining by approximately 15% due to increased medical costs and revised guidance. Despite these challenges, recent investor sentiment shows a shift, with UNH becoming a top holding in the Schwab U.S. Dividend Equity ETF.
Analysts remain optimistic, projecting a potential 32% increase in UNH's stock value. Expectations for the first quarter include an earnings per share (EPS) of $6.65, an 8% decrease from the previous year, largely attributed to higher medical expenses within its Medicare Advantage segment. Revenue is anticipated to remain stable at around $109.58 billion.
Recent analyst upgrades, such as John Ransom of Raymond James, highlight potential for improved earnings upside and enhanced G&A efficiency. UnitedHealth has also taken internal steps, including the closure or sale of underperforming clinics, to bolster its margins and address operational concerns.
